{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-140873","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.254501+00:00","generated_at":"2026-05-19T08:30:24.217997+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Quince raises $11.5M in private placement of stock and warrants; management participates","bullets":["Sold 6,671,928 shares, 2M pre-funded warrants, and 8,671,928 common warrants for $11.5M gross proceeds.","Common warrants exercisable at $1.20/share for 5 years; pre-funded warrants exercisable at $0.001/share.","Management investors: CEO Dirk Thye ($200k), COO Brendan Hannah ($50k), President Charles Ryan ($10k).","Company to file resale registration statement within 120 days under Registration Rights Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-140873","json":"https://secwatch.observer/filing/0001193125-25-140873.json","markdown":"https://secwatch.observer/filing/0001193125-25-140873.md","text":"https://secwatch.observer/filing/0001193125-25-140873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/0001193125-25-140873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:30:24.217997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}